Want to see AU:EDE full AI Analyst Report?
Top Page
Eden Innovations
(Sydney:EDE)
Select Model
Select Model
Rating:42Neutral
Price Target:
AU$0.08
▼(-5.00% Downside)
Action:Upgraded
Date:09/06/26
The score is primarily constrained by weak financial performance: persistent losses, negative margins (including negative gross profit), and ongoing negative operating/free cash flow suggest an elevated turnaround/financing risk profile. Technicals add pressure, with price trading below all key moving averages and negative MACD indicating a downtrend. Valuation does not offset these risks because the negative P/E reflects lack of profitability and dividend yield data is unavailable.
Positive Factors
Low latest-year leverage
The latest balance-sheet snapshot shows very low leverage and positive equity, giving Eden Innovations a stronger near-term financial base than its earlier periods. This can preserve flexibility for operations and investment, provided management can reduce losses and avoid renewed financing strain.
Negative Factors
Persistent unprofitable operations
Persistent losses and deeply negative operating and net margins indicate that the current business model is not yet producing sustainable earnings. Without a durable improvement in pricing, cost absorption, or operating efficiency, revenue recovery alone may not translate into shareholder value.
Read all positive and negative factors
Positive Factors
Negative Factors
Low latest-year leverage
The latest balance-sheet snapshot shows very low leverage and positive equity, giving Eden Innovations a stronger near-term financial base than its earlier periods. This can preserve flexibility for operations and investment, provided management can reduce losses and avoid renewed financing strain.
Read all positive factors
Eden Innovations (EDE) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$49.92M
Dividend YieldN/A
Average Volume (3M)796.05K
Price to Earnings (P/E)―
Beta (1Y)0.53
Revenue Growth-18.73%
EPS Growth-1646.32%
CountryAU
Employees35
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)-0.57
Shares Outstanding631,879,700
10 Day Avg. Volume581,038
30 Day Avg. Volume796,051
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.10
Price to Sales (P/S)0.71
P/FCF Ratio-0.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Eden Innovations Business Overview & Revenue Model
Company Description
Eden Innovations Ltd specializes in providing environmentally conscious technological solutions. The company is involved in the creation, production, and sales of several key products, including EdenCrete, a concrete admixture enhanced with carbon...
How the Company Makes Money
null...
Eden Innovations Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
46
Neutral
Cash Flow
22
Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.98M | 2.43M | 2.02M | 4.70M | 4.15M |
| Gross Profit | -2.35M | 1.68M | 1.39M | -2.17M | -3.36M |
| EBITDA | -3.97M | -3.93M | -4.83M | -15.08M | -4.49M |
| Net Income | -4.98M | -6.93M | -7.55M | -17.87M | -6.65M |
Balance Sheet | |||||
| Total Assets | 19.09M | 17.84M | 19.07M | 17.00M | 25.79M |
| Cash, Cash Equivalents and Short-Term Investments | 5.41M | 561.18K | 975.20K | 2.53M | 1.55M |
| Total Debt | 1.23M | 16.34M | 12.79M | 10.21M | 4.91M |
| Total Liabilities | 5.08M | 19.59M | 15.10M | 12.28M | 6.30M |
| Stockholders Equity | 14.02M | -1.75M | 3.98M | 4.73M | 19.49M |
Cash Flow | |||||
| Free Cash Flow | -4.61M | -3.70M | -5.27M | -5.11M | -7.51M |
| Operating Cash Flow | -4.49M | -3.70M | -5.22M | -4.17M | -6.03M |
| Investing Cash Flow | 5.93M | -305.20K | -586.79K | -940.93K | -1.48M |
| Financing Cash Flow | 3.53M | 3.59M | 4.26M | 6.09M | 6.78M |
Eden Innovations Technical Analysis
Negative
0.08
Price Trends
0.05
Negative
Market Momentum
>-0.01
Positive
45.27
Neutral
22.34
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:EDE, the sentiment is Negative. The current price of 0.08 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 45.27 is Neutral, neither overbought nor oversold. The STOCH value of 22.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:EDE.
Eden Innovations Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | AU$5.83B | 59.09 | 3.26% | 2.48% | 13.49% | -37.41% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | AU$37.64M | -33.82 | -7.59% | ― | 23.31% | 50.00% | |
45 Neutral | AU$4.37M | -1.35 | -41.16% | 0.41% | 308.85% | -44.44% | |
45 Neutral | AU$31.96M | -5.53 | -14.21% | 1.40% | -0.09% | -228.23% | |
42 Neutral | AU$49.92M | -0.14 | -39.26% | ― | -18.73% | -1646.32% | |
41 Neutral | AU$49.34M | -7.43 | -27.29% | ― | ― | 29.52% |
* Industrials Sector Average
AU:EDE
Eden Innovations
0.08
0.04
125.71%
AU:PET
Phoslock Environmental Technologies Limited
0.01
-0.02
-66.67%
AU:CWY
Cleanaway Waste Management
2.60
-0.07
-2.62%
AU:EGL
Environmental Group Limited
0.08
-0.18
-67.69%
AU:ECT
Environmental Clean Technologies Limited
0.11
0.05
83.33%
AU:DEM
De.mem Ltd.
0.12
<0.01
4.55%
Eden Innovations Corporate Events
Eden Innovations Cuts Losses and Clears Debt as OptiBlend Sales Rise
Aug 31, 2026
Eden Innovations reported a 19% fall in revenue to $1.98 million for the year to 30 June 2026, with EdenCrete sales down and OptiBlend revenue up 10% on demand from data centre back-up power customers in the U.S. The net loss after tax narrowed to...
Eden Innovations Boosts Managing Director’s Equity Through Share and Performance Rights Issuance
Aug 11, 2026
Eden Innovations Ltd has updated the market on changes to Managing Director Allan Larsen’s indirect holdings, reflecting adjustments to his equity-based compensation arrangements. The director’s interests are held through a family trus...
Eden Innovations Sets September Expiry for 29 Million ASX-Listed Options
Aug 6, 2026
Eden Innovations has notified holders that 29,113,998 quoted options, exercisable at $0.18 each under the ASX code EDEOD, will expire at 5:00pm AWST on 11 September 2026, with official quotation to cease on 7 September 2026. Option holders may exe...
Eden Innovations Issues Shares to Settle Director Fees and Loans
Aug 4, 2026
Eden Innovations Ltd is an Australia-based company listed on the ASX under the ticker EDE, operating in the industrial technology and materials sector. The company focuses on developing and commercialising innovative products and solutions, with i...
Eden Innovations Issues 21 Million Unquoted Performance Rights Under Incentive Scheme
Aug 4, 2026
Eden Innovations Ltd has announced the issuance of 21,000,000 unquoted Performance Rights, expiring on 4 August 2029, under its employee incentive scheme. The move reinforces the company’s use of long-term equity incentives to align employee...
Eden Innovations Issues 3 Million Unquoted Options in Strategic Equity Move
Aug 4, 2026
Eden Innovations Ltd has issued 3 million unquoted options in three equal tranches, each with different exercise prices of $0.20, $0.30 and $0.40, all expiring on 4 August 2028. The options form part of previously announced transactions and are no...
Eden Innovations Issues Large Tranche of Unquoted Options and Performance Rights
Aug 4, 2026
Eden Innovations has issued a significant tranche of unquoted equity securities, comprising 10 million unlisted options exercisable at $0.25 expiring in August 2029, 25 million unlisted options exercisable at $0.35 expiring in August 2030, and 5 m...
Eden Innovations Issues 71.25 Million New Unlisted Options
Aug 4, 2026
Eden Innovations Ltd, an ASX-listed entity under ticker EDE, has filed a notification regarding changes to its unquoted equity securities. The release is focused on the company’s capital management actions, with no further details on its ope...
Eden Innovations Seeks ASX Quotation for Over 20 Million New Shares
Aug 4, 2026
Eden Innovations Ltd, listed on the ASX under the code EDE, operates in the innovation-driven technology space and raises equity capital through ordinary fully paid shares. Its focus on commercialising new solutions is underpinned by regular acces...
Eden Innovations Seeks ASX Quotation for Additional Ordinary Shares
Aug 3, 2026
Eden Innovations Ltd has applied for quotation on the ASX of 34,669 ordinary fully paid shares, to be issued on 3 August 2026. The new securities arise from the exercise or conversion of existing options or other convertible instruments, slightly ...
Eden Innovations ramps up EdenCrete rollout and enters FY2027 debt-free
Jul 31, 2026
Eden Innovations reported strong quarterly progress, driven by accelerating adoption of its EdenCrete Pz7 dosage systems across North American ready-mix concrete plants and expansion into new U.S. states, Canada, and ongoing trials in India and ot...
Eden Innovations Wins Strong Shareholder Backing for Capital and Incentive Resolutions
Jul 24, 2026
Eden Innovations has reported that all resolutions put to shareholders at its 24 July 2026 general meeting were passed by poll without amendment, signalling strong investor support for recent capital management initiatives. The approvals cover rat...
Eden Innovations Expands EdenCrete Pz7 Reach Across North American Amrize Plants
Jul 22, 2026
Eden Innovations is extending its EdenCrete Pz7 footprint in North America via new installations at Amrize concrete plants in Texas, Minnesota and the greater Toronto area. The advanced admixture, designed to boost concrete strength and enable cem...
Eden Innovations Wins Strong Endorsement in Indian Government Concrete Trials
Jul 22, 2026
Eden Innovations reported positive results from Indian government-led trials of its EdenCrete Pz7 concrete additive, conducted by the Central Road Research Institute in Delhi on mixes used for new highways and thin concrete overlays. The carbon na...
UBS Drops Below Substantial Holder Threshold in Eden Innovations
Jul 6, 2026
Eden Innovations Ltd operates in the technology and innovation sector, focusing on the development and commercialization of advanced materials and related solutions. The company is listed in Australia and its shareholder base includes institutiona...
Eden Innovations Sets July 2026 General Meeting and Moves Further Online With Shareholder Communications
Jun 25, 2026
Eden Innovations Ltd has scheduled a General Meeting of shareholders to be held in person at the company’s Perth offices on 24 July 2026 at 11:00 a.m. AWST, with the formal Notice of Meeting and Explanatory Memorandum made available online v...
UBS Group exits substantial holding in Eden Innovations
Jun 24, 2026
UBS Group AG and its related bodies corporate have notified Eden Innovations that they ceased to be a substantial shareholder in the company as of 22 June 2026. The change, formalised in a statutory Form 605 notice signed on 24 June 2026, indicate...
Eden Innovations Reports Strong EdenCrete Trials in India’s Booming Concrete Market
Jun 22, 2026
Eden Innovations reported strong trial results for its EdenCrete Pz7 additive in India’s concrete market, with tests in the Delhi region showing higher strength and abrasion resistance at low dosages in both road and high-strength mixes. The...
Eden Innovations Seeks Quotation for New Share Issue on ASX
Jun 19, 2026
Eden Innovations Ltd has applied to the ASX for quotation of 693,736 new ordinary fully paid shares, to be issued on 19 June 2026. The additional securities arise from the exercise or conversion of existing options or other convertible instruments...
Eden Innovations Completes Final Tranche of $4 Million Share Placement
Jun 9, 2026
Eden Innovations has completed the second and final tranche of its institution-led capital raising, issuing 14,166,666 fully paid ordinary shares at $0.18 each to secure $2.55 million before costs. This brings the total placement to $4 million and...
Eden Innovations Seeks Quotation for Second Tranche of Placement Shares
Jun 9, 2026
Eden Innovations has applied to the ASX for quotation of 14,166,666 new ordinary fully paid shares, representing the second tranche of a placement previously announced in April 2026. The additional capital from this placement is expected to suppor...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.